SEC Form 4 · accession 0001093557-17-000006
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorge A Valdes
Officer — CTO
Period of report
Jan 9, 2017
Accepted (ET)
Jan 11, 2017 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2017 | M | 7,000 | $7.79 | A | 79,334 | D | |
| Common StockF1,F2,F3 | Jan 9, 2017 | S | 7,000 | $63.0232 | D | 72,334 | D | |
| Common Stock | Jan 9, 2017 | M | 417 | $7.63 | A | 72,751 | D | |
| Common StockF1,F4,F3 | Jan 9, 2017 | S | 417 | $63.4875 | D | 72,334 | D | |
| Common Stock | Jan 9, 2017 | M | 900 | $3.19 | A | 73,234 | D | |
| Common StockF1,F5,F3 | Jan 9, 2017 | S | 900 | $63.3118 | D | 72,334 | D | |
| Common Stock | Jan 9, 2017 | M | 2,583 | $7.63 | A | 74,917 | D | |
| Common StockF1,F6,F3 | Jan 9, 2017 | S | 2,583 | $62.8291 | D | 72,334 | D | |
| Common StockF7 | holding | — | — | — | 3,499 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $7.63 | Jan 9, 2017 | M | 417 | D | May 19, 2009 | May 19, 2018 | Common Stock | 417 | 10,000 | D |
| Incentive Stock Option (right to buy) | $7.79 | Jan 9, 2017 | M | 7,000 | D | Aug 2, 2008 | Aug 2, 2017 | Common Stock | 7,000 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $7.63 | Jan 9, 2017 | M | 2,583 | D | May 19, 2009 | May 19, 2018 | Common Stock | 2,583 | 0 | D |
| Non-Qualified Stock Option (right to buy)F8 | — | Jan 9, 2017 | M | 900 | D | Dec 11, 2009 | Dec 11, 2018 | Common Stock | 900 | 100 | D |
Explanation of responses
- F1On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $62.48 to $63.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
- F4This transaction was executed in multiple trades at prices ranging from $63.37 to $63.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F5This transaction was executed in multiple trades at prices ranging from $63.17 to $63.37. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- F6This transaction was executed in multiple trades at prices ranging from $62.49 to $63.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
- F7Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
- F8Conversion or exercise price of derivative security is $3.19.